PFIZER FLOP: Drugmaker Pfizer Inc. shares drop in sales of dishes in the first quarter, amounting to generic competition, a decrease in revenue forecasts and pressure to sell shares of the growing company.
Results: the world largest Drugmaker earned a net income of $ 2.22 billion, or 28 cents per share, up to 10% due to declining costs. Revenue was $ 16.5 billion, just below Wall Street expectations.
THE problem: Pfizer some promising drugs in development, but it has not found a way to offset losses of patents for blockbuster Lipitor cholesterol and other drugs major or to boost its price depressed.
No comments:
Post a Comment